The secret to a successful cataract surgery in diabetics lies in making informed decisions. Instead of being influenced by ...

A study, published in Science Translational Medicine, revealed that diabetic mice in induced periods of low sugar were ...

Thanks to advancements in early detection and treatment options, it's possible to live a long and healthy life after being ...

Jacksonville Lions Club and Lions of Illinois Foundation will offer free hearing and retinal screenings in Jacksonville.

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

The global sales of ophthalmic lasers are estimated to be worth USD 976.8 million in 2024 and are anticipated to reach a value of USD 1,561.0 million by 2034. Sales are projected to rise at a CAGR of ...

Fear is a natural response when something threatens your vision—but it’s also a signal to act quickly. Some retinal ...

Telangiectatic capillaries may have potential clinical relevance for diagnosis and treatment of diabetic macular edema.

The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ranibizumab, is delivered through an ocular implant that is refilled every nine ...

Prolonged UV exposure has serious risks for your eyes including cataracts, growths and even cancer. Fortunately, protecting ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) 100 mg/mL for the ...